Listen

Description

What if wearable technology could do more than track your steps—what if it could listen to radio signals drifting through your bloodstream to monitor your health in real time? In this episode of Science at the Fifty-Third Degree, host Dr. Nayiar Shahid sits down with Dr. Peter Light from the Department of Pharmacology at the University of Alberta to explore where pharmacology meets radio waves and artificial intelligence.
Dr. Light unpacks two major medical discoveries from his career: why a class of diabetes drugs designed for the kidneys (SGLT2 inhibitors) unexpectedly reduces heart failure events by 40%, and how his lab engineered WaveSense—a needle-free continuous glucose monitor that uses radio frequencies and AI algorithms to measure blood sugar without test strips or consumables.
This episode covers:
● The heart-kidney mystery: How SGLT2 inhibitors offer direct cardioprotection even though SGLT2 receptors aren't expressed in the heart.
● How radio frequencies combined with AI match the accuracy of traditional glucose sensors completely non-invasively.
● Fostering intrinsic motivation: How real-time trend visualization helps prevent Type 2 diabetes far better than static finger-prick numbers.
● The "Beyond Glucose" initiative: Adapting radio frequency software to measure other vital blood metabolites like lactate and ketones.

Note: Science at the Fifty-Third Degree is produced by the University of Alberta Basic Science Administrative Team and is available on the Aviary platform and wherever you listen to podcasts. Questions or feedback? Reach us at basicsci@ualberta.ca.